Related Experiment Video

Updated: Aug 18, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Familial hypercholesterolemia in children

J Rodenburg1, M N Vissers, A Wiegman

  • 1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands.

Insights

Children with familial hypercholesterolemia experience accelerated atherosclerosis. Early statin therapy is safe and effective in reducing low-density lipoprotein cholesterol and improving arterial health in these children.

Area of Science:

  • Pediatric Cardiology
  • Genetics
  • Cardiovascular Disease

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels from birth.
  • Children with FH face an increased risk of premature cardiovascular disease due to accelerated atherosclerosis.
  • Early detection and intervention are crucial for managing FH in pediatric populations.

Purpose of the Study:

  • To review recent advancements in diagnosing and managing pediatric familial hypercholesterolemia.
  • To highlight the impact of early lipid-lowering interventions on cardiovascular health in children with FH.

Main Methods:

  • Cross-sectional cohort study analyzing intima-media thickness progression in children with FH.
  • Evaluation of low-density lipoprotein cholesterol as a predictor of atherosclerosis.
  • Assessment of statin therapy and plant sterol products for lipid reduction and surrogate marker improvement.

Main Results:

  • Children with FH showed a 5-fold faster increase in carotid arterial wall intima-media thickness compared to unaffected siblings.
  • Low-density lipoprotein cholesterol levels were a strong predictor of intima-media thickness.
  • Statin therapy led to regression of intima-media thickness and was found to be safe in children, without impairing growth or development.
  • Plant sterols reduced low-density lipoprotein cholesterol but did not improve endothelial function.

Conclusions:

  • Children with FH significantly benefit from lipid-lowering strategies, particularly statins.
  • Statins are safe and effective in reducing low-density lipoprotein cholesterol and improving atherosclerosis markers in pediatric FH.
  • Early initiation of statin therapy is recommended as the pivotal treatment for children with familial hypercholesterolemia.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...